Structural Basis for Ligand Regulation of the Fatty Acid-binding Protein 5, Peroxisome Proliferator-activated Receptor β/δ (FABP5-PPAR β/δ) Signaling Pathway

被引:84
|
作者
Armstrong, Eric H. [1 ,2 ]
Goswami, Devrishi [3 ]
Griffin, Patrick R. [3 ]
Noy, Noa [4 ,5 ]
Ortlund, Eric A. [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA
[4] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA
基金
美国能源部;
关键词
RETINOIC ACID; NUCLEAR-LOCALIZATION; PPAR-BETA/DELTA; L-FABP; ALPHA; GLUCOSE; TRANSPORT; DIFFERENTIATION; ELECTROSTATICS; PURIFICATION;
D O I
10.1074/jbc.M113.514646
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fatty acid-binding proteins (FABPs) are a widely expressed group of calycins that play a well established role in solubilizing cellular fatty acids. Recent studies, however, have recast FABPs as active participants in vital lipid-signaling pathways. FABP5, like its family members, displays a promiscuous ligand binding profile, capable of interacting with numerous long chain fatty acids of varying degrees of saturation. Certain "activating" fatty acids induce the protein's cytoplasmic to nuclear translocation, stimulating PPAR beta/delta transactivation; however, the rules that govern this process remain unknown. Using a range of structural and biochemical techniques, we show that both linoleic and arachidonic acid elicit FABP5's translocation by permitting allosteric communication between the ligand-sensing beta 2 loop and a tertiary nuclear localization signal within the alpha-helical cap of the protein. Furthermore, we show that more saturated, non-activating fatty acids inhibit nuclear localization signal formation by destabilizing this activation loop, thus implicating FABP5 specifically in cis-bonded, polyunsaturated fatty acid signaling.
引用
收藏
页码:14941 / 14954
页数:14
相关论文
共 50 条
  • [1] A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor agonists
    Patil, Rahul
    Mohanty, Biswaranjan
    Liu, Bonan
    Chandrashekaran, Indu R.
    Headey, Stephen J.
    Williams, Martin L.
    Clements, Craig S.
    Ilyichova, Olga
    Doak, Bradley C.
    Genissel, Patrick
    Weaver, Richard J.
    Vuillard, Laurent
    Halls, Michelle L.
    Porter, Christopher J. H.
    Scanlon, Martin J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (10) : 3720 - 3734
  • [2] FATTY-ACID ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)
    BOCOS, C
    GOTTLICHER, M
    GEARING, K
    BANNER, C
    ENMARK, E
    TEBOUL, M
    CRICKMORE, A
    GUSTAFSSON, JA
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 53 (1-6): : 467 - 473
  • [3] Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-α-dependent
    Landrier, JF
    Thomas, C
    Grober, J
    Duez, H
    Percevault, F
    Souidi, M
    Linard, C
    Staels, B
    Besnard, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) : 45512 - 45518
  • [4] Comparative analysis of fatty acid-binding protein 4 promoters: Conservation of peroxisome proliferator-activated receptor binding sites
    Shin, J.
    Li, B.
    Davis, M. E.
    Suh, Y.
    Lee, K.
    [J]. JOURNAL OF ANIMAL SCIENCE, 2009, 87 (12) : 3923 - 3934
  • [5] A structural basis for the activation of peroxisome proliferator-activated receptor gamma (PPARγ) by perfluorooctanoic acid (PFOA)
    Pederick J.L.
    Frkic R.L.
    McDougal D.P.
    Bruning J.B.
    [J]. Chemosphere, 2024, 354
  • [6] Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis
    Yan, Tingting
    Luo, Yuhong
    Yan, Nana
    Hamada, Keisuke
    Zhao, Nan
    Xia, Yangliu
    Wang, Ping
    Zhao, Changdong
    Qi, Dan
    Yang, Shoumei
    Sun, Lulu
    Cai, Jie
    Wang, Qiong
    Jiang, Changtao
    Gavrilova, Oksana
    Krausz, Kristopher W.
    Patel, Daxesh P.
    Yu, Xiaoting
    Wu, Xuan
    Hao, Haiping
    Liu, Weiwei
    Qu, Aijuan
    Gonzalez, Frank J.
    [J]. HEPATOLOGY, 2023, 77 (01) : 239 - 255
  • [7] Structural Basis for the Improved Potency of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists
    Peng, Yi-Hui
    Coumar, Mohane Selvaraj
    Leou, Jiun-Shyang
    Wu, Jian-Sung
    Shiao, Hui-Yi
    Lin, Chia-Hui
    Lin, Wen-Hsing
    Lien, Tzu Wen
    Chen, Xin
    Hsu, John T. -A.
    Chao, Yu-Sheng
    Huang, Chien-Fu
    Lyu, Ping-Chiang
    Hsieh, Hsing-Pang
    Wu, Su-Ying
    [J]. CHEMMEDCHEM, 2010, 5 (10) : 1707 - 1716
  • [8] Macrophage programming is regulated by a cooperative interaction between fatty acid binding protein 5 and peroxisome proliferator-activated receptor γ
    El Kharbili, Manale
    Aviszus, Katja
    Sasse, Sarah K.
    Zhao, Xiaoyun
    Serban, Karina A.
    Majka, Susan M.
    Gerber, Anthony N.
    Gally, Fabienne
    [J]. FASEB JOURNAL, 2022, 36 (05):
  • [9] Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) α and PPARγ
    Shipley, JM
    Waxman, DJ
    [J]. MOLECULAR PHARMACOLOGY, 2003, 64 (02) : 355 - 364
  • [10] Cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α (PPAR α)
    Watanabe, K
    Takahashi, T
    Kodama, M
    Aizawa, Y
    Ashino, H
    Tazawa, S
    Inoue, M
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 162P - 162P